Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

PROSTAID Calgary’s 2022 Pathfinder Award went to Dr. Geoffrey Gotto, who presented on new research and innovations in metastatic castration-sensitive prostate cancer (MCSPC) that is leading to longer survival and greater quality of life in prostate cancer patients who do combinations of treatments to combat the cancer.

Dementia and the PREVENT Study

Dr. Philip Barber, the Associate Professor of Neurology and Radiology at the University of Calgary, talks about the difference faces of dementia, the 9 different risk factors and the steps you can take to PREVENT the disease before it becomes untreatable. He also introduces a study where you could help us further understand dementia and what we can do to cure it in the future.

Being a Caregiver (when you didn’t plan on it)

Don Wood is volunteer extraordinaire and the current co-chair for the Cancer Strategic Clinical Network (C-SCN) Alberta Cancer Diagnosis Initiative (ACDI) and a member of the Core SCN Committee for Alberta Health Services. After his wife passed away from a hard-fought battle with cancer, Don made it his mission to help others to try and make the health care world a better place for those who would come there after him.

MRI Guided Prostate Radiotherapy

Radiation Oncologists from the Tom Baker Cancer Centre, Dr. Harvey Quon and Dr. Sangjune Lee come for a talk on new innovations in digital imaging, including real-time MRI workflows that allow for more accurate and customizable treatment of prostate cancer. They compare older capturing techniques and methodologies as they demonstrate how simulation, planning and delivery today are now much different and improved as Calgary welcomes their new Calgary Cancer Centre in 2023 to champion even further innovation.